Evidence map›Paper›PMID 33089589›Full record

ReviewPhytotherapy research : PTR2021

An evaluation of the effects and safety of Zuogui pill for treating osteoporosis: Current evidence for an ancient Chinese herbal formula.

Jinyu Li, Kai Sun, Baoyu Qi, Guiyu Feng, Wei Wang, Qi Sun, Chengying Zheng, Xu Wei, Yusong Jia

Open access · hybridAbstract readReview
In one paragraph

Review in Phytotherapy research : PTR, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 3 pooled it
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 3 syntheses or guidelines pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Total Flavonoids Isolated from the Leaves ofCurrent pharmaceutical design · 2024
    Article
  12. Zuogui and Yougui pills improve perimenopausal syndrome regulation of apoptosis in mice.Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan · 2023
    Article
  13. Article
  14. Frontiers in medicine · 2023
    Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Jinyu LiDepartment of Orthopaedics, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
Kai SunDepartment of Spine, Wangjing Hospital, China Academy of Chinese Medical Sciences, Beijing, China.ORCID https://orcid.org/0000-0002-2167-3066
Baoyu QiDepartment of Spine, Wangjing Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Guiyu FengDepartment of Graduate School, Beijing University of Chinese Medicine, Beijing, China.
Wei WangDepartment of Graduate School, Beijing University of Chinese Medicine, Beijing, China.
Qi SunDepartment of Orthopaedics, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
Chengying ZhengDepartment of Orthopaedics, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
Xu WeiDepartment of Scientific Research, Wangjing Hospital, China Academy of Chinese Medical Sciences, Beijing, China.ORCID https://orcid.org/0000-0001-6723-9604
Yusong JiaDepartment of Orthopaedics, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine · CNChinese Academy of Medical Sciences & Peking Union Medical College · CNBeijing University of Chinese Medicine · CN

Funding

Foundation for Young Talents Training of China Association of Chinese Medicine Grant number: CACM-2017-QNRC2-A03National Natural Science Foundation of China Grant number: 81704102
6 · The paper itself

Abstract

The aim of this study is to systematically evaluate existing evidence of the Chinese herbal formula, Zuogui pill (ZGP), for the treatment of osteoporosis. A systematic literature search was performed in six electronic databases. The authors independently extracted data in pairs and evaluated the risk of bias. A total of 221 articles were identified initially, of which 12 relevant studies were enrolled. The primary outcome was fracture incidence and bone mineral density (BMD) at different sites. Bone metabolism markers, clinical symptoms, quality of life, and adverse events or adverse drug reactions (ADRs) were secondary outcomes. The results showed that ZGP, combined with anti-osteoporosis drugs, significantly increased BMD at the lumbar spine, Ward's area, and total hip. In terms of markers for improved bone metabolism, ZGP plus conventional drugs dramatically improved the levels of alkaline phosphatase, bone Gla protein, bone alkaline phosphatase, and tartrate-resistant acid phosphatase. Gastrointestinal discomfort, dizziness, and fatigue were found in the combined therapy group. Although the results indicate that ZGP is a potential candidate for osteoporosis, evidence remains insufficient. Further rigorously designed and high-quality trials with a larger sample size are warranted to verify the current conclusions.

Indexed as

Drugs, Chinese HerbalFemaleHumansMaleOsteoporosisDrugs, Chinese HerbalzuoguiChinese herbal formulaosteoporosissystematic reviewZuogui pill

Identifiers

PMID33089589
PMCPMC8246738
OpenAlexW3093917531

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.